GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Assets | ₹7,428 Cr | ₹8,424 Cr | ₹8,282 Cr | ₹7,360 Cr | ₹6,804 Cr |
What is the latest Total Current Assets ratio of GLENMARK PHARMACEUTICALS ?
Year | Total Current Assets |
---|---|
Mar2024 | ₹7,428 Cr |
Mar2023 | ₹8,424 Cr |
Mar2022 | ₹8,282 Cr |
Mar2021 | ₹7,360 Cr |
Mar2020 | ₹6,804 Cr |
How is Total Current Assets of GLENMARK PHARMACEUTICALS Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹7,428 Cr | -11.82 | |
Mar2023 | ₹8,424 Cr | 1.71 | |
Mar2022 | ₹8,282 Cr | 12.54 | |
Mar2021 | ₹7,360 Cr | 8.17 | |
Mar2020 | ₹6,804 Cr | - |
Compare Total Current Assets of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹40,810.4 Cr | 1.9% | 4.8% | 41.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹417,400.0 Cr | -3.3% | 3.4% | 13.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,844.0 Cr | 4.1% | 15.2% | 60.2% | Stock Analytics | |
CIPLA | ₹121,328.0 Cr | 0.6% | 5.6% | 11.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,521.0 Cr | 1.9% | 3.7% | 28.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,043.0 Cr | 6.2% | 11.4% | 2.6% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 1.9% |
4.8% |
41.7% |
SENSEX | 2.7% |
11.8% |
14% |
You may also like the below Video Courses